GlassScriptPhysician profile
Isa Vazquez
NPI 1235619107
$1,222.39
in general payments reported to CMS, 2019-2025
12 companies · $165 in 2025
The $165 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $503 · 2022: $155 · 2023: $223 · 2024: $177 · 2025: $165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $564.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $564.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $593.66 | 2021-2025 | Xtampza |
| Biodelivery Sciences International, INC. | $191.14 | 2021 | |
| Redhill Biopharma INC. | $75.02 | 2021-2022 | |
| Almatica Pharma LLC | $69.19 | 2022-2023 | Gralise |
| Saluda Medical Americas, INC. | $66.32 | 2025 | Evoke |
| Amgen INC. | $44.62 | 2022 | |
| Scilex Pharmaceuticals INC. | $41.21 | 2021 | |
| Spinal Simplicity, LLC | $37.96 | 2023-2024 | Ha Minuteman G3-R |
| Nalu Medical, INC. | $30.31 | 2021 | |
| Merit Medical Systems INC | $28.75 | 2021 | |
| Virtus Pharmaceuticals LLC | $27.34 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $16.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Isa Vazquez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.